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Polypharmacy and medicines optimisation: best practice for care 
homes 
Background 
Medicines prevent, treat or manage many illnesses or conditions and are the most 
common intervention in the NHS.  According to the Health Survey for England 2016, 
48% of adults had taken at least one prescribed medicine in the last week, a figure 
that increased to more than 90% in those aged over 75 years (Health and Social 
Care Information Centre, 2017).  The financial cost of prescribed medication to the 
NHS is significant.  In 2016/17, approximately £9 billion was spent on prescribing in 
primary care in England (NHS Digital, 2017). 
Medicines have a huge potential to do good and without medicines many older 
people would function less well, have a reduced quality of life or die at an earlier age.  
For example, the seasonal influenza vaccination can protect against acute 
respiratory infections caused by the influenza virus, statins can reduce 
cardiovascular morbidity and mortality, antibiotics and corticosteroids can be 
effective in managing exacerbations of chronic obstructive pulmonary disease, and 
strong opioids can relieve severe pain at the end of life.  
Despite these benefits, older people are at increased risk of medicines-related 
problems.  Drug treatment is made more complex by the ageing process.  The risk of 
iatrogenic injury is increased by changes in the ability of the body to absorb, 
distribute, metabolise and eliminate medicines (pharmacokinetics).  Similarly, the risk 
of injury is increased by differences in how drugs effect older people compared to 
younger people (pharmacodynamics).   These pharmacokinetic and 
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pharmacodynamics changes are responsible for greater and more prolonged drug 
effects in older people.  Premarketing drug trails often exclude older people and 
approved doses may not be appropriate.  Many medicines need to be used with 
special caution in older people.  Drugs that are poorly tolerated in frail older people 
include antipsychotics, nonsteroidal anti-inflammatory drugs, digoxin (250mcg or 
more), benzodiazepines, anticholinergics, and combination analgesics (NHS 
Scotland, 2015). 
The ageing process also increases the likelihood that an older person will need 
concurrent medication for more than one long term condition.  As the number of 
medicines a person is taking increases, so does the possibility of adverse drug 
events.  Such events result in significant morbidity, mortality and healthcare costs.  
Studies in general adult populations indicate that 6.5% of hospital admissions are 
due to adverse drug events, with over 73% these either definitely or possibly 
avoidable (Pirmohamed et al., 2004).   
In March 2017, the World Health Organization launched the Global Patient Safety 
Challenge: Medication without Harm, which aims to reduce severe avoidable 
medication harm by 50% in the next five years.  This paper takes up the challenge 
and considers medicines use in care homes and the evidence informing best 
practice in polypharmacy and medicines optimisation. 
Defining polypharmacy and medicines optimisation 
The term polypharmacy is used to describe the concurrent use of multiple 
medication.  The most commonly reported definition is the use of five or more 
medicines a day (Masnoon et al., 2017).  The Kings Fund (2013) present two 
discrete concepts:  appropriate polypharmacy and problematic polypharmacy (see 
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Box 1).  This distinction acknowledges that polypharmacy has the potential to be 
beneficial for some patients, but also harmful if poorly management. 
Medicines optimisation is defined by UK Medicines Information as: an approach that 
seeks to maximise the beneficial clinical outcomes for patients from medicines with 
an emphasis on safety, governance, professional collaboration and patient 
engagement (UK Medicines Information, 2012: P. 1).  The Royal Pharmaceutical 
Society (2013) elaborate and describe a process focused on ensuring that the right 
patients get the right choice of medicine at the right time; a process that may involve 
stopping some medicines (deprescribing) as well as starting others, and the 
consideration of lifestyle changes and non-pharmacological options to reduce the 
need for medicines.  It should be noted that medicines optimisation is not 
synonymous with medication management, it has a more holistic focus such that 
medication management might be seen as a subcomponent within the broader 
concept of medicines optimisation.   
Medicines use by older people in care homes 
The majority of older people living in care homes have high levels of dependency, 
cognitive impairment, multi-morbidity and polypharmacy.  For example, a recent 
study of 227 residents across eleven care homes in the UK found that the average 
age of residents was 85 years, each with six separate diagnoses and eight different 
medicines (Gordon et al., 2014).  A number of research studies have highlighted 
prescribing and the management of medicines as key areas for quality improvement 
in care homes.  For example, Barber et al (2009) examined medication errors 
amongst 256 residents across 55 care homes in the UK.  They found that 69% of 
residents (n=178) had been exposed to one or more medication error.  These 
included errors in administration, dispensing, prescribing, and monitoring.  The most 
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common errors in prescribing related to omission of strength or route, unnecessary 
medicines, incorrect dose or strength, and omitted drugs.  It is not known whether or 
not these errors would necessarily have caused harm.  It is also important to note 
that the results of this study may not be representative of all care homes in the UK.  
However, problems relating to the prescription of unnecessary medicines in care 
home residents have been reported in other studies.  For example, Parsons et al 
(2012) examined medication records for instances of inappropriate prescribing for 
older people with dementia in six care homes in the UK.  Medication records were 
scrutinised at two time points: at the first, 119 records were examined and 46% of 
residents (n=55) were found to have been prescribed one or more potentially 
inappropriate medicine and at the second, 110 records were examined and 40% of 
residents (n=45) were prescribed one or more potentially inappropriate medicine.  At 
both time points, antipsychotics were the most frequently prescribed potentially 
inappropriate medicine; in 26% of cases, patients did not need the medicine and in 
58% of cases, the risks of taking the medicine were felt to outweigh the benefits. 
Improving medicines outcomes for older people in care homes 
Quality improvement endeavours should be underpinned by the best available 
evidence.  The National Institute for Health and Social Care Excellence (NICE) has 
produced two salient evidence based guidelines: Managing Medicines in Care 
Homes (NICE, 2014), and Medicines Optimisation: The safe and effective use of 
medicines to enable the best possible outcomes (NICE, 2015).  The latter make 
seven recommendations for health and social care in England (see Box 2).   
Practitioners need to know and understand these guidelines in order to determine 
whether current ways of working must change to ensure the best care is provided to 
patients.  This paper will consider the application of a selection of the 
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recommendations contained within the medicines optimisation guidelines in the 
context of improving medicines outcomes for older people in care homes.   
Systems for identifying, reporting and learning from medicines-related safety incidents 
As previously reported, medication errors are all too frequent events in care homes.  
NICE (2014; 2015) recommend that systems are put in place to identify medication 
errors.  These systems include health record review, patient surveys, and direct 
observation of medication administration.  Such systems should be in place in all 
care homes where medicine is administered. 
As soon as an error is identified, immediate medical assistance should be sought to 
ensure the safety of the resident.  Incidents should then be reported internally and to 
relevant external organisations where appropriate.  Incidents will not normally need 
to be reported to the Care Quality Commission (CQC) unless they result in death or 
injury, relate to allegations of abuse, or are incidents reported to or investigated by 
the police (CQC, 2018a).  Such incidents are known as notifiable incidents and need 
to be submitted in writing within a predetermined timescale.   
Regardless of circumstances, all medication errors should be recorded in the 
resident’s records and logged locally in a manner that ensures records are 
accessible for external stakeholder review.  Duty of candour requires that as soon as 
practicable, the resident or the person acting on their behalf should be informed that 
an incident has occurred.  Some medication events should be reported to the local 
authority as adult safeguarding incidents.  Such events include: deliberate 
withholding of medicines without a valid reason, incorrect use of medicines for 
reasons other than the benefit of the patient, deliberate attempts to harm through the 
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use of medicine, and accidental harm caused by incorrect administration or 
medication error (CQC, 2018a).   
Once an incident is reported, an investigation should be initiated to trace the error 
back to its root causes and to identify how a similar error could be prevented in the 
future, or actions to minimise the impact should such an error occur.  There is an 
expectation that regular meetings should be held with everyone involved with 
medicines in the care home team to share learning from these investigations and 
ensure necessary changes are put into practice.  Lessons should also be circulated 
to other care homes as appropriate.   
Medicines-related communication systems when patients move from one care setting to 
another 
Research indicates that care home residents are at increased risk of hospital 
admission.  For example, using Hospital Episode Statistics and information held on 
the CQC database of registered care home providers for older people, Quality Watch 
(2015) estimated that care home residents had between 40 and 50% more 
emergency admissions and accident and emergency attendances than the general 
population aged 75 and over.  Given high rates of hospital admission and 
attendances amongst this population, inter-institutional transfers and ensuring 
patient safety across settings is of paramount importance.  The absence of complete 
and accurate medicines information can lead to prescribing errors during hospital 
admission and on return to the care home.   
When a person moves from one care setting to another, NICE (2014; 2015) 
recommend that relevant information about medicines should be shared with 
patients, their family members, and between health and social care practitioners.  
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Providers should ensure that a clear and up to date list of current medicines 
accompanies the patient.  The electronic transfer of this information is encouraged; 
however, the use of faxes should be avoided due to the potential for breaches in 
patient confidentiality and because faxes can be hard to read (Royal Pharmaceutical 
Society, 2016). 
Medicines reconciliation 
Older people are often prescribed complex medication regimens.  For example,  
regimens that include more than one prescribed medicine, medicines that are taken 
regularly as well as some that are only taken when required, doses of medicine that 
are not constant but depend on the results of blood tests, and medicines prescribed 
by more than one prescriber (Royal Pharmaceutical Society, 2007).  The complexity 
of these regimens is often compounded the use of complementary medicines and 
the addition of new medicines.   
Medicines reconciliation is a concept that was first proposed by the US Institute for 
Healthcare Improvement (2004).  It is defined as the process of identifying an 
accurate list of a person's current medicines and comparing them with the current list 
in use, recognising any discrepancies, and documenting any changes, thereby 
resulting in a complete list of medicines, accurately communicated (NICE, 2015: 20). 
The importance of medicines reconciliation in avoiding medicines is emphasised by 
NICE (2014; 2015).  The CQC (2018) propose that a clear and up to date list of 
current medicines should be produced for each resident when they are first admitted 
to the care home, when they are discharged from hospital, when their treatment 
changes, and before the first dose is administered or as soon as possible afterwards.  
When discrepancies are identified, there is an expectation that the person 
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undertaking the reconciliation process will consult an appropriate healthcare 
professional to ensure these discrepancies are resolved. 
Medication review 
As we have seen, many medicines need to be used with special caution in older 
people because of age related pharmacokinetics and pharmacodynamics.  A 
structured medication review is defined as a critical examination of a person’s 
medicines with the objective of reaching an agreement with the person about 
treatment, optimising the impact of medicines, minimising the number of medication-
related problems and reducing waste (NICE, 2015: 22).   
There is an expectation that medication reviews will be carried out at least annually 
for older people in care homes and more frequently as required (NICE, 2014).  
Triggers for more frequent reviews include when a resident has been recently 
diagnosed with a long term condition, experienced a suspected adverse drug event, 
or requested that a medicine be stopped.  The National Prescribing Centre (2008) 
advice that either a prescriber (medical or non-medical prescriber) or a specialist 
practitioner (e.g. diabetic nurse specialist, or community pharmacist accredited to 
provide a clinical medication review as an enhanced service) conduct these reviews.  
Furthermore, NICE (2014) recommend that the review of any resident in a care 
home should involve the wider multidisciplinary team. 
According to NHS Scotland (2015) medicines review involves seven key steps: 
identify aims and objectives of drug therapy, identify essential drug therapy, establish 
whether the patient is taking unnecessary drug therapy, assess whether therapeutic 
objectives are being achieved, establish whether the patient is at risk of adverse 
drug events or is suffering actual adverse drug events, consider whether drug 
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therapy is cost effective, and explore whether the patient is willing and able to take 
drug therapy as intended.  To further guide the conduct of medication reviews, the 
Screening Tool of Older Person’s Prescriptions (STOPP) and the Screening Tool to 
Alert doctors to Right Treatment (START) (Gallagher et al., 2008) were developed to 
provide explicit, evidence based rules to avoid commonly encountered instances of 
potentially inappropriate prescribing and potential prescribing omissions.  These 
tools recognise the potential to not only taper, withdraw, discontinue or stop 
medicines (de-prescribe) but also add new prescription medicine as required. NICE 
(2015) advocate the use of use of the STOPP/START criteria in medication reviews 
and a recent systematic review of randomised controlled trials involving these tools 
found their use in both acute and long-term care reduced falls, delirium episodes, 
hospital length-of-stay, care visits (primary and emergency) and medication costs 
(Hill-Taylor et al., 2016).  It did not however find evidence of improvements in quality 
of life or mortality. 
Medicines-related models of organisation and cross-sector working 
NICE (2015) recommend that organisations consider new cross-sector models of 
care for patients to optimise their medicines.  Cross sector service provision is 
defined as independent, yet interconnected sectors working together to better meet 
the needs of patients and improve the quality and effectiveness of service provision 
(Winters et al., 2016: 1).  One such model is the deployment of expert pharmacy 
teams to work in care homes (NHS England, 2018).  Deployment is intended to 
provide care home residents with equity of access to a clinical pharmacist prescriber 
as a member of the multidisciplinary team, and care homes with access to pharmacy 
technicians who will ensure the efficient and supply and management of medicines 
within the care home.  An exemplar is provided by the Proactive Care Homes 
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Pharmacists Project, which was commissioned by North West London Integrated 
Care Programme Innovation Fund.  This project aimed to standardise provision of 
care and target the causes of non-elective preventable hospital admissions.  Local 
evaluations highlight the benefits of the project, including the early identification of 
prescribing errors, inadequate patient monitoring, adverse drug reactions, and 
suboptimal prescribing (Goh et al., 2017).  A reduction in ambulance call outs and 
falls were also reported (Central London Community Healthcare NHS Trust, 2018). 
Summary  
Older people in care homes often experience polypharmacy and suboptimal 
medication outcomes.  Efforts to improve medication outcomes should be 
underpinned by the best available evidence.  Recommendations for improving 
outcomes include systems for identifying, reporting and learning from medicines-
related patient safety incidents, medicines reconciliation, medication review, and 
medicines-related models of organisation and cross-sector working.  Everyone 
involved in medicines has a part to play in medicines optimisation.  Practitioners 
working in care home settings must reflect on whether current ways of working need 
to change to ensure the best care is provided to patients. 
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Box 1:  Defining Polypharmacy (Kings Fund, 2016) 
Appropriate Polypharmacy Problematic polypharmacy 
Prescribing for an individual for complex 
conditions or for multiple conditions in 
circumstances where medicines use 
has been optimised and where the 
medicines are prescribed according to 
best evidence 
Problematic polypharmacy is the 
prescribing of multiple medications 
inappropriately, or where the intended 
benefit of the medication is not realised 
 
Box 2:  Recommendations for Medicines Optimisation (NICE, 2015) 
• Systems for identifying, reporting and learning from medicines-related patient 
safety incidents 
• Medicines reconciliation 
• Medication review 
• Self-management plans 
• Patient decision aids used in consultations involving medicines 
• Clinical decision support 
• Medicines-related models of organisation and cross-sector working 
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